A Novel Computer-Based Therapy for Social Anxiety
Status: | Recruiting |
---|---|
Conditions: | Anxiety, Healthy Studies, Psychiatric |
Therapuetic Areas: | Psychiatry / Psychology, Other |
Healthy: | No |
Age Range: | 18 - 60 |
Updated: | 9/12/2018 |
Start Date: | August 25, 2017 |
End Date: | August 1, 2020 |
Contact: | Franklin Schneier, MD |
Email: | Fschneier@nyspi.columbia.edu |
Phone: | 646-774-8041 |
The present study is a double blind trial that seeks to examine the feasibility,
acceptability, efficacy, and mechanism of a recently developed eye-tracking-based therapy
(GC-MRT) in individuals with social anxiety disorder (SAD)
acceptability, efficacy, and mechanism of a recently developed eye-tracking-based therapy
(GC-MRT) in individuals with social anxiety disorder (SAD)
The present study is a double blind trial that seeks to examine the feasibility,
acceptability, efficacy, and mechanism of a recently developed eye-tracking-based therapy
(GC-MRT) in individuals with social anxiety disorder (SAD). The purpose of this study is to
assess whether a brief computer-based research treatment, provided in 30 minutes sessions
twice a week for 4 weeks, helps improve social anxiety symptoms, and by what mechanism. The
study will also assess the effect of research treatments on brain activity using a scan
called magnetic resonance imaging (MRI).
acceptability, efficacy, and mechanism of a recently developed eye-tracking-based therapy
(GC-MRT) in individuals with social anxiety disorder (SAD). The purpose of this study is to
assess whether a brief computer-based research treatment, provided in 30 minutes sessions
twice a week for 4 weeks, helps improve social anxiety symptoms, and by what mechanism. The
study will also assess the effect of research treatments on brain activity using a scan
called magnetic resonance imaging (MRI).
Inclusion Criteria:
- Males and females between the ages of 18 and 60
- Current DSM-V primary diagnosis of SAD
- Score of at least 50 on the Liebowitz Social Anxiety Scale (Self-rated version)
- Fluent in English and willing and able to give informed written consent and
participate responsibly in the protocol
- Normal or corrected-to-normal vision
Exclusion Criteria:
- Present or past psychotic episode, psychotic disorder, schizophrenia, schizoaffective
disorder, or bipolar disorder
- Current severe depression
- Suicidal ideation or behavior
- Current diagnosis of PTSD, obsessive-compulsive disorder, bipolar disorder, manic
episode or tic disorder
- Current or past organic mental disorder, seizure disorder, epilepsy or brain injury
- Current unstable or untreated medical illness
- Severe alcohol use disorder, severe cannabis use disorder, and any severity of other
substance use disorder (except nicotine use disorders allowed)
- Use of psychiatric medication in the past month other than a stable dose of selective
serotonin reuptake inhibitors (SSRIs) for a least 3 months
- Any concurrent cognitive behavioral therapy; other psychotherapy that was initiated in
the past 3 months
- Pregnancy, or plans to become pregnant during the period of the study - will be
assessed by Urine β-HCG
- Contraindication to MRI scanning:
- Paramagnetic metallic implants or devices contraindicating magnetic resonance imaging
or any other non-removable paramagnetic metal in the body (e.g. pacemaker,
paramagnetic metallic prosthesis, surgical clips, shrapnel, necessity for constant
medicinal patch, some tattoos)
- Being unable to tolerate the scanning procedures (i.e., severe obesity,
claustrophobia)
We found this trial at
1
site
1051 Riverside Dr
New York, New York 10032
New York, New York 10032
646-774-5000
Principal Investigator: Franklin Schneier, MD
New York State Psychiatric Institute The New York State Psychiatric Institute (NYSPI), established in 1895,...
Click here to add this to my saved trials